Is Liver Transplant Curative in Homozygous Familial Hypercholesterolemia? A Review of Nine Global Cases
出版年份 2022 全文链接
标题
Is Liver Transplant Curative in Homozygous Familial Hypercholesterolemia? A Review of Nine Global Cases
作者
关键词
-
出版物
ADVANCES IN THERAPY
Volume 39, Issue 6, Pages 3042-3057
出版商
Springer Science and Business Media LLC
发表日期
2022-04-26
DOI
10.1007/s12325-022-02131-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Familial Hypercholesterolemia in the Arabian Gulf Region: Clinical results of the Gulf FH Registry
- (2021) Khalid F. Alhabib et al. PLoS One
- Practice of lipoprotein apheresis and short-term efficacy in children with homozygous familial hypercholesterolemia: Data from an international registry
- (2020) Luirink Ik et al. ATHEROSCLEROSIS
- Inclisiran Durably Lowers Low-Density Lipoprotein Cholesterol and Proprotein Convertase Subtilisin/Kexin Type 9 Expression in Homozygous Familial Hypercholesterolemia
- (2020) G. Kees Hovingh et al. CIRCULATION
- Evinacumab for Homozygous Familial Hypercholesterolemia
- (2020) Frederick J. Raal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Case Report: Liver Transplantation in Homozygous Familial Hypercholesterolemia (HoFH)—Long-Term Follow-Up of a Patient and Literature Review
- (2020) Matej Mlinaric et al. Frontiers in Pediatrics
- Management of dyslipidemia in adult solid organ transplant recipients
- (2019) Bruce A. Warden et al. Journal of Clinical Lipidology
- Clinical management, psychosocial characteristics, and quality of life in patients with homozygous familial hypercholesterolemia undergoing LDL-apheresis in Turkey: Results of a nationwide survey (A-HIT1 registry)
- (2019) Meral Kayikcioglu et al. Journal of Clinical Lipidology
- Small Dense Low‐Density Lipoprotein Cholesterol Predicts Cardiovascular Events in Liver Transplant Recipients
- (2019) Mohammad Bilal Siddiqui et al. HEPATOLOGY
- The Impact of Coronary Artery Disease and Statins on Survival after Liver Transplantation
- (2019) Samarth S. Patel et al. LIVER TRANSPLANTATION
- Prevalence of frailty among kidney transplant candidates and recipients in the United States: Estimates from a National Registry and Multicenter Cohort Study
- (2019) Christine E. Haugen et al. AMERICAN JOURNAL OF TRANSPLANTATION
- A nation-wide survey of patients with homozygous familial hypercholesterolemia phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry)
- (2018) Meral Kayikcioglu et al. ATHEROSCLEROSIS
- Treatment-related and health-related quality of life in lipoprotein apheresis patients
- (2018) V. De Gucht et al. Journal of Clinical Lipidology
- Target achievement and cardiovascular event rates with Lomitapide in homozygous Familial Hypercholesterolaemia
- (2018) Dirk J. Blom et al. Orphanet Journal of Rare Diseases
- Liver Transplantation for Homozygous Familial Hypercholesterolemia
- (2018) Yasushi Ishigaki et al. Journal of Atherosclerosis and Thrombosis
- Rapidly progressive atherosclerosis after domino liver transplantation from a teenage donor with homozygous familial hypercholesterolemia
- (2017) Jessica R. Golbus et al. Journal of Clinical Lipidology
- Dyslipidemia after pediatric renal transplantation-The impact of immunosuppressive regimens
- (2017) Sandra Habbig et al. PEDIATRIC TRANSPLANTATION
- Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG study
- (2017) Frederick J Raal et al. Lancet Diabetes & Endocrinology
- Effects of Liver Transplantation on Lipids and Cardiovascular Disease in Children With Homozygous Familial Hypercholesterolemia
- (2016) Mercedes Martinez et al. AMERICAN JOURNAL OF CARDIOLOGY
- HEART UK statement on the management of homozygous familial hypercholesterolaemia in the United Kingdom
- (2016) Michael France et al. ATHEROSCLEROSIS
- Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association
- (2016) Barbara S. Wiggins et al. CIRCULATION
- European Society of Cardiology/European Atherosclerosis Society Task Force consensus statement on proprotein convertase subtilisin/kexin type 9 inhibitors: practical guidance for use in patients at very high cardiovascular risk
- (2016) Ulf Landmesser et al. EUROPEAN HEART JOURNAL
- Alirocumab in patients with heterozygous familial hypercholesterolemia undergoing lipoprotein apheresis: Rationale and design of the ODYSSEY ESCAPE trial
- (2016) Patrick M. Moriarty et al. Journal of Clinical Lipidology
- Clinical and molecular characteristics of homozygous familial hypercholesterolemia patients: Insights from SAFEHEART registry
- (2016) Rodrigo Alonso et al. Journal of Clinical Lipidology
- Progressive Aortic Stenosis in Homozygous Familial Hypercholesterolemia After Liver Transplant
- (2016) Margaret Greco et al. PEDIATRICS
- Lipids in liver transplant recipients
- (2016) Anna Hüsing et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Systematic Review of Low‐Density Lipoprotein Cholesterol Apheresis for the Treatment of Familial Hypercholesterolemia
- (2016) Anthony Wang et al. Journal of the American Heart Association
- Lipoprotein Apheresis
- (2015) Patrick M. Moriarty et al. CARDIOLOGY CLINICS
- Identification and Treatment of Patients with Homozygous Familial Hypercholesterolaemia: Information and Recommendations from a Middle East Advisory Panel
- (2015) Abdullah Al-Ashwal et al. Current Vascular Pharmacology
- Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment
- (2015) Albert Wiegman et al. EUROPEAN HEART JOURNAL
- Evolution of serum atherogenic risk in liver transplant recipients: Role of lipoproteins and metabolic and inflammatory markers
- (2015) Ravi Chhatrala et al. LIVER TRANSPLANTATION
- Liver transplantation as a definitive treatment for familial hypercholesterolemia: A series of 36 cases
- (2015) Mohsenreza Mansoorian et al. PEDIATRIC TRANSPLANTATION
- Transmission ofLDLRMutation From Donor Through Liver Transplantation Resulting in Hypercholesterolemia in the Recipient
- (2014) K. Nikkilä et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
- (2014) M. Cuchel et al. EUROPEAN HEART JOURNAL
- Lipoprotein apheresis: State of the art and novelties
- (2013) C. Stefanutti et al. ATHEROSCLEROSIS SUPPLEMENTS
- Apheresis in homozygous familial hypercholesterolemia: The results of a follow-up of all Norwegian patients with homozygous familial hypercholesterolemia
- (2012) Asgeir Græsdal et al. Journal of Clinical Lipidology
- Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study
- (2012) Marina Cuchel et al. LANCET
- Long-term Medical Management of the Liver Transplant Recipient: What the Primary Care Physician Needs to Know
- (2012) Siddharth Singh et al. MAYO CLINIC PROCEEDINGS
- Pediatric aspects of Familial Hypercholesterolemias: Recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia
- (2011) Stephen R. Daniels et al. Journal of Clinical Lipidology
- Calcineurin Inhibitors in Liver Transplantation: To Be or Not to Be
- (2011) J.F. Castroagudín et al. TRANSPLANTATION PROCEEDINGS
- Evolution of Causes and Risk Factors for Mortality Post-Liver Transplant: Results of the NIDDK Long-Term Follow-Up Study
- (2010) K. D. S. Watt et al. AMERICAN JOURNAL OF TRANSPLANTATION
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started